PRECONDITIONS FOR STUDY START Sample Clauses

PRECONDITIONS FOR STUDY START. Precondition for the start of the study is the approval of the project by the competent authority which will be applied by the CRO. Patient recruitment in the centre may only start on condition that the competent ethics commission has given its favourable opinion to the clinical study and the Institution’s/Investigator’s participation. Where necessary CRO will support the Institution/Investigator in the application procedure for the ethic commission’s opinion and notifications to the authorities concerned on participation of the Institution/Investigator as required by local regulations. CRO will not deliver any study medication to the study site unless confirmation is available that the above mentioned demands are met. Ethics Commission CRO will provide all documents needed for submission to the appropriate ethics commission. If accepted by the ethics commission, CRO will apply for the ethics committee’s opinion on behalf of the Investigator and pass the procedures. In case the ethics commission raises any objections against the subject or any procedures of the planned study, the contracting parties will discuss and propose modifications which meet the concerns of the ethics commission as well as the objectives of the study. The study may not start in the centre unless written evidence of approval of the appropriate ethics commission is available. The ethics commission must be informed on each modification and/or additional statement concerning the study protocol (amendments). CRO will provide all necessary documentation and will assist the Investigator in submission of any amendment or will inform the ethics commission directly, if accepted by the ethics commission. Notification of the Authority(ies) CRO will apply for study authorisation at the competent health authority and, if applicable, notify other authorities concerned on participation of the Investigator/the study site as required by local regulations and where necessary in agreement with Investigator. The Investigator will be informed in writing about the notifications done by CRO. The study may not start unless all needed approvals/confirmations by the authority(ies) are available. The responsible authorities may perform an inspection of the study site to verify the correct conduct of the study. PŘEDPOKLADY PRO ZAHÁJENÍ STUDIE Předpokladem pro zahájení studie je schválení projektu příslušným úřadem, o které požádá CRO. Nábor pacientů může v centru začít pouze v případě, že příslušná etická komis...
AutoNDA by SimpleDocs
PRECONDITIONS FOR STUDY START. Precondition for the start of the study is the approval of the project by the competent authority which will be applied by the CRO. Patient recruitment in the centre may only start on condition that the competent ethics commission has given its favourable opinion to the clinical study and the Institution’s/Investigator’s participation. Where necessary CRO will support the Institution/Investigator in the application procedure for the ethic commission’s opinion and notifications to the authorities concerned on participation of the Institution/Investigator as required by local regulations. CRO will not deliver any study medication to the study site unless confirmation is available that the above mentioned demands are met. 6.1
PRECONDITIONS FOR STUDY START. Precondition for the start of the study is the approval of the project by the competent authority (the State Institute for Drug Control) which will be applied by, and for which completeness and correctness as well as for the correctness of all further legal documentations for the implementation for the study, is responsible the CRO. Patient recruitment in the centre may only start on condition that the competent ethics commission has given its favourable opinion to the clinical study and the Institution’s/Investigator’s participation. Where necessary CRO will support the Institution /Investigator in the application procedure for the ethic commission’s opinion and notifications to the authorities concerned on participation of the Institution/Investigator as required by the law regulations of the Czech Republic. CRO will not deliver any study medication to the study site unless confirmation is available that the above mentioned demands are met. 6.1

Related to PRECONDITIONS FOR STUDY START

  • Solicitations for Subcontracts, Including Procurement of Materials and Equipment In all solicitation, either by competitive bidding or negotiation, made by the Contractor for work to be performed under a subcontract, including procurement of materials or leases of equipment, each potential Subcontractor or supplier shall be notified by the Contractor of the Contractor’s obligations under this Agreement and the Regulations relative to non-discrimination on the grounds of race, color, or national origin.

  • Time for Completion The Contractor shall deliver the material and/or services called for in the specifications/proposal and within the delivery time specified and in accordance with the terms of the contract. Work shall be completed within 30 days from the Notice to Proceed issued by the City of Sparks Purchasing Division. The Contractor shall not alter or vary any terms or conditions contained or incorporated herein, including but not limited to, the quantity, price, delivery date or date designated as After Receipt of Order (ARO) or date for commencement or completion of services as mutually agreed upon, unless such alteration or variation is consented to in writing by a duly authorized representative of the City. The City reserves the right to cancel resultant Contract upon ten days written notice in the event the type and quality of the product or work performance is unsatisfactory or in default, subject to Contractor’s right to cure as outlined in termination clause. This is a non-exclusive Contract and the City reserves the right to acquire the material and/or services at its discretion, from other sources during the term of this Contract.

  • Instructions for Operators This agreement is intended to be provided to an Operator from a LEA. The Operator should fully read the agreement and is requested to complete the below areas of the agreement. Once the Operator accepts the terms of the agreement, the Operator should wet sign the agreement and return it to the LEA. Once the LEA signs the agreement, the LEA should provide a signed copy of the agreement to the Operator. Article/Exhibit Box # Description Cover Page Box # 3 Official Name of Operator Cover Page Box # 4 Date Signed by Operator Recitals Box #5 Contract Title for Service Agreement Recitals Box #6 Date of Service Agreement Article 7 Boxes #7-10 Operator’s designated representative Signature Page Boxes #15-19 Authorized Operator’s representative signature Exhibit A Box #25 Description of services provided Exhibit B All Applicable Boxes  Operator notates if data is collected to provide the described services.  Defines the schedule of data required for the Operator to provide the services outlined in Exhibit A Exhibit D All Applicable Boxes (Optional Exhibit): Defines deletion or return of data expectations by LEA Exhibit E All Applicable Boxes (Optional Exhibit): Operator may, by signing the Form of General Offer of Privacy Terms (General Offer, attached as Exhibit E), be bound by the terms of this DPA to any other Subscribing LEA who signs the acceptance in said Exhibit. Exhibit F Boxes # 25-29 A list of all Subprocessors used by the Operator to perform functions pursuant to the Service Agreement, list security programs and measures, list Operator’s security measures

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!